The IHE Life Sciences Market Access Program supports Alberta and British Columbia-based life sciences companies with promising, market-ready healthcare technology that are currently seeking market access in Canada or beyond. Support includes the development of an economic model to quantify the adoption case for procurement, as well as an Evidence Development Plan to guide collection of data from on-market routine clinical use in order to update model assumptions and strengthen the economic evidence to support further market access opportunities.
Call for Expressions of Interests is due October 8th, 2021.
